How is IGF-1 DES administered?
This describes how IGF-1 DES is typically administered in clinical and research references, not a self-administration guide. The usual route is Subcutaneous, often site-specific, on a daily, post-workout schedule, generally over 4 weeks max. Specific dosing is individual and beyond general information, and human evidence for IGF-1 DES is limited.
Administration at a glance (reference data)
- Route: Subcutaneous, often site-specific
- Schedule: Daily, post-workout
- Cycle length: 4 weeks max
- Half-life: ~30 minutes
References
- Insulin-like growth factor-I (IGF-I) and especially IGF-I variants are anabolic in dexamethasone-treated rats — Tomas FM, Knowles SE, Owens PC, et al., Biochemical Journal, 1992
- Mechanisms of IGF-1-Mediated Regulation of Skeletal Muscle Hypertrophy and Atrophy — Yoshida T & Delafontaine P, Cells, 2020
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on IGF-1 DES
Last updated 2026-06-15.